This site is intended for health professionals only!

Published on 9 September 2009

Share this story:

Glaxo urged to join HIV patent pool


GlaxoSmithKline (GSK) has been urged to waive patent protection on HIV drugs to make them more available to Aids sufferers in developing countries.

A letter from 15 organisations, including the Stop Aids Campaign, Medecins Sans Frontieres, Unicef and Christian Aid, wants GSK to join a patent pool being put together by Unitaid.

This would allow cheap generic copies to be made without legal restraint or delays from the manufacturers, which enjoy patent protection for 20 years.

The appeal follows an story in the Guardian newspaper in which GSK boss Andrew Witty outlines his reservations about such a pool.

But he also says: “I’m not saying no to anything, because nobody’s actually put in front of me a really concrete proposition.”

He points out that that GSK already funds research into drugs for children, and he is prepared to allow generic companies make cheap copies of its HIV drugs under license.

Copyright Press Association 2009


Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story: